First experience of durable cytoreduction in chronic lymphoid leukemia with 177Lu-DOTATATE

Authors :: Stéphane Roux
Niklaus Schaefer
Alberic Bressoud
Marie Nicod-Lalonde
Tijana Savovic
John O. Prior
Marie Meyer
Source :: Medical Oncology. 36
Publication Year :: 2019
Publisher :: Springer Science and Business Media LLC, 2019.
Abstract: This is the first described case of effective and durable cytoreduction after PRRT with 177Lu-DOTATATE in a 75-year-old female, with B cell chronic lymphoid leukemia, and well-differentiated metastatic neuroendocrine tumor.

Subjects :: Cancer Research
medicine.medical_specialty
PET-CT
Hematology
business.industry
Chronic lymphoid leukemia
General Medicine
03 medical and health sciences
B-Cell Chronic Lymphoid Leukemia
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Internal medicine
medicine
Cancer research
business

Tools